Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection...
Principal Investigator Mathias Munschauer aims to better understand SARS-CoV-2. He now receives funding of 1.5 million euros for his research project “COVIDecode” from the European Research Council (ERC). Munschauer is...
Silke Tannapfel, former Administrative Director, will leave the Helmholtz Centre for Infection Research (HZI) in Braunschweig on 31 December 2021 to take on new professional challenges as Ministerial Director in the...
The increasing spread of resistant germs means that formerly highly effective antibiotics are often not successful anymore in treating infectious diseases. To counteract this development, the team led by Prof. Anna...
Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Cambridge have revealed the molecular details of a genetic switch through their work on the 2A protein...
The rapid expansion of the Omicron variant has taken the international medical and scientific community by surprise. After infection or vaccination against the coronavirus, our bodies produce antibodies that play a key...
Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig demonstrate for the first time how ZAP, a protein of the...
Since 2017, interested citizen scientists can collect soil samples as part of the "Sample’ das Saarland" campaign and send them to the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site...
Between July 2020 and August 2021, the Epidemiology Department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig examined the blood of approximately 26,000 individuals for antibodies against the...
